Élaboré en collaboration avec Sun Pharma
(disponible en anglais seulement)

Inside Out: Multidisciplinary Perspectives on Androgen-Driven Acne Management

Inside Out follows the inner workings of three different types of patients with acne; a transgender man, a patient with polycystic ovarian syndrome, and a patient taking anabolic-androgenic steroids. Each patient is guided by three physicians – a dermatologist, psychiatrist, and endocrinologist. From the Headquarters, the control centre for patient care, the physicians will lead us through the intricacies of managing these complex patients, discussing the function of androgens in acne development, and the role of multidisciplinary care. The audience will see each specialist’s perspective on management, as well as how they collaborate to provide a holistic treatment plan.

Élaboré en collaboration avec Johnson & Johnson
(disponible en anglais seulement)

And Canada Takes the Lead! Canada as a Leader in Dermatology for Skin of Colour

Skin comes in different colors – what about your approaches to treatment? There is a growing focus in dermatology on the unmet needs for patients with skin of colour. Experts around the world are working to achieve consensus on best practices for people of colour in many conditions, including psoriasis. Canadian dermatologists have a prominent role in these developments, and this practically-oriented symposium will provide an opportunity to interact with a panel of experts in this growing field. In addition to reviewing recent data specific to patients with skin of colour, this symposium is meant to improve diagnostic and communication skills to help you provide better care across the spectrum of skin tones.

Faculty

Geeta Yadav, MD, MHS, FRCPC (Toronto, ON)
Marissa Joseph, MD, FRCPC (Pediatrics), FRCPC (Dermatology) (Toronto, ON)
Parbeer Grewal, MD, FRCPC, FAAD (Edmonton, AB)
Rachel Asiniwasis, MD, MS(HS), FRCPC, FAAD (Regina, SK)

Learning Objectives

At the end of this symposium, participants will be able to:

• Classify severity of inflammation in patients with skin of colour.
• Adopt appropriate terminology to describe features of disease in patients with skin of colour.
• Integrate key considerations specific to skin of colour into practice to improve care across diverse skin types.

Élaboré en collaboration avec Pfizer
(disponible en anglais seulement)

Making Headway: Patient and Physician Views on Severe Alopecia Areata

Did you know that the leading cause of childhood hair loss is alopecia areata (AA)? AA is a complex disease to diagnose and manage as it is often associated with comorbid conditions and significantly impacts psychosocial wellbeing. Once diagnosed, patients and caregivers embark on a challenging journey to manage the unpredictable progression of the disease with limited treatments and use of supportive interventions. Adopting a conversational approach, this symposium aims to make headway on the evolution of AA management through the views of the patient, caregiver and physician, while addressing the emotional impact on adolescents. It intends to foster empathy, discuss novel treatments, and tools to enhance dermatologist training for AA diagnosis and clinical management.

Faculty

Dermatologist Chair and Presenter: Julien Ringuet, MD, MSc, FRCPC (Québec, QC)
Dermatologist Presenter: Cathryn Sibbald, MD, MSc, FRCPC, DABD (Toronto, ON)
Patient Presenter: Leah Morton (Toronto, ON)
Caregiver Presenter: Shannon Morton (Toronto, ON)

Learning Objectives

At the end of this symposium, participants will be able to:

• Accurately diagnose and classify alopecia areata based on disease severity, comorbidities, and patient factors.
• Manage severe alopecia areata through shared decision making based on predictors of response to current and emerging therapies, and supportive interventions.
• Explain the impact of alopecia areata from the perspective of an adolescent patient and the caregiver through their lived experiences and preferences.

Élaboré en collaboration avec Novartis
(disponible en anglais seulement)

The HS Times – Headliners: Accelerating Care, Optimizing Outcomes and Redefining Clinic Efficiency

Three hidradenitis suppurativa (HS) experts will examine the critical aspects of HS management that can be effectively optimized to improve patient outcomes. Journalists of a metaphorical journal, the HS Times, they will review clinical data and work with the audience to shape the evidence for an article slated for publication the following day. What strategies can be implemented to expedite diagnosis, early intervention and timely referrals? Which therapeutic approaches lead to better outcomes? How can clinic workflow be optimized by streamlining processes to reduce delays and enhance overall efficiency in managing HS patients in clinic? The symposium will engage the audience in addressing these questions through a mix of didactic presentations, discussion and interactive polling.

Faculty

Jessica Asgarpour, BSc, MD, FRCPC, FAAD, DABD (Toronto, ON)
Irina Turchin, MD, FRCPC, DABD (Fredericton, NB)
Christopher Keeling, MD, FRCPC, FAAD (Edmonton, AB)

Learning Objectives

At the end of this symposium, participants will be able to:

• Identify the factors contributing to delayed diagnosis in HS and evaluate procedural strategies for the management of the condition.
• Review the evolution of HS management strategies, approved therapies and investigational treatments.
• Discuss practical strategies to improve HS clinic visit efficiency.